Cite
MLA Citation
K.H. Jung et al.. “1956 Safety and tolerability of subcutaneous trastuzumab for HER2-positive early breast cancer in patients with lower body weight and in Asian patients: SafeHer Phase III study subgroup analyses.” European journal of cancer, vol. 51, n.d., pp. S318–. http://access.bl.uk/ark:/81055/vdc_100030628182.0x00000a